Utah CTSI calls for applications to our R01 Writing Group (February 2023 submission deadline), a comprehensive, 6-month program utilizing a multi-faceted approach to provide you with the tools and knowledge needed to write a successful R01 or equivalent application.
The Utah CTSI STARS TL1 Training Program welcomes applications for a PhD post-doctoral position. The Utah CTSI STARS program provides pre- and post-doctoral training opportunities in translational research across 3 spheres of emphasis (Discover, Demonstration, and Dissemination) that together define our STARS, or Spheres of Translation Across the Research Spectrum.
Submitting a first successful R01 is a major challenge. The University's KL2 program, a part of the Clinical and Translational Science Institute, is again organizing R01 writing groups that will include up to five NIH defined new investigators who are pursuing their first R01 NIH award (or equivalent). Each group will be headed by one or two senior faculty members with extensive success with NIH awards and study section reviewer experience. The groups will foster peer and senior mentoring to produce top quality grant submissions.
The Utah Clinical and Translational Science Institute (CTSI) is now accepting research proposals for pre-submission peer review. The program accepts proposals from investigators conducting research at any point along the translational science spectrum aiming to improve the health of individuals and the public. Please limit one proposal submission per investigator to the PGR. NIH review criteria will be used to score each submission.
The Utah CTSI STARS TL1 Training Program welcomes applications from PhD and MD pre-doctoral and post-doctoral positions. The Utah CTSI STARS Program provides pre- and post-doctoral training opportunities in translational research across 3 spheres of emphasis (Discover, Demonstration, and Dissemination) that together define our Spheres of Translation Across the Research Spectrum (STARS). We would especially like to encourage applications by those who are underrepresented in clinical and translational science.